Sep 21, 2020 - Biotech firms and drugmakers across the globe are pumping in millions of dollars to develop a vaccine to wipe out the deadly coronavirus.
Sep 18, 2020 - AstraZeneca (AZN) resumes its coronavirus vaccine study in the United Kingdom. Merck (MRK) inks two oncology deals with Seattle Genetics.
Sep 17, 2020 - The pending merger of Pfizer's (PFE) Upjohn unit with Mylan (MYL) is on track to close in the fourth quarter of 2020 as almost all necessary regulatory clearances are in place.
Sep 16, 2020 - BioNTech (BNTX) receives grant of up to almost $445 million to support development and potential approval of its coronavirus vaccine candidate.
Sep 15, 2020 - Investors might want to consider buying stocks that also provide income via dividends given the current interest rate environment...
Sep 15, 2020 - U.S. stock markets closed higher on Monday reversing some of the losses of the last week.
Sep 13, 2020 - The ability to globally distribute a vaccine is as important as the vaccine itself. To the best-equipped victors go the spoils.
Sep 11, 2020 - AstraZeneca (AZN) halts coronavirus vaccine study. FDA approves Roche (RHHBY) and Glaxo's (GSK) medicines.
Sep 09, 2020 - The COVID-19 vaccine developers pledge to observe high ethical standards and sound scientific principles in conducting clinical studies and manufacturing of vaccines.
Sep 01, 2020 - U.S. stock markets closed mostly lower on Monday as investors booked profit after a week-long rally.